Unilever continues weed-out
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Niall FitzGerald, the new Unilever chairman, confirmed his strategy of weeding out non-core businesses yesterday when the company sold a micro- biology division to venture capital group CinVen.
CinVen is buying the professional micro-biology unit of the conglomerate's Unipath business in a deal worth pounds 84.6m. This includes fresh banking facilities to fund expansion and Unilever yesterday declined to reveal the precise sale price.
Though not technically a management buyout, CinVen will retain the group's existing management. They are also expected to obtain a stake in the business which has 600 staff and recorded sales of pounds 60m last year.
The business, which will be renamed Oxoid, is based in Basingstoke and manufactures materials used by hospitals, pathology units and the food and pharmaceutical industries.
Outside the UK, Oxoid also has manufacturing plants in Germany and sales offices across Europe, Australia and Canada.
Unilever will concentrate on Unipath's consumer goods activities which are based in Bedford. They include the Clearblue pregnancy test kits and the recently launched Persona systems of contraception.
Mr FitzGerald, who took over the reins at Unilever in September, stated previously that he wanted to dispose of underperforming or non-core businesses. Unilever sold Mrs Butterwell, an American syrups and pancakes business, just before Christmas.
Mr FitzGerald has already slimmed down Unilever's group executive committee and plans to merge some operating subsidiaries into a simpler structure.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments